202 related articles for article (PubMed ID: 10998134)
1. Coexpression of integrin alpha(v)beta3 and matrix metalloproteinase-2 (MMP-2) coincides with MMP-2 activation: correlation with melanoma progression.
Hofmann UB; Westphal JR; Waas ET; Becker JC; Ruiter DJ; van Muijen GN
J Invest Dermatol; 2000 Oct; 115(4):625-32. PubMed ID: 10998134
[TBL] [Abstract][Full Text] [Related]
2. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
3. Expression of integrin alpha(v)beta(3) correlates with activation of membrane-type matrix metalloproteinase-1 (MT1-MMP) and matrix metalloproteinase-2 (MMP-2) in human melanoma cells in vitro and in vivo.
Hofmann UB; Westphal JR; Van Kraats AA; Ruiter DJ; Van Muijen GN
Int J Cancer; 2000 Jul; 87(1):12-9. PubMed ID: 10861447
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN
Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
[TBL] [Abstract][Full Text] [Related]
5. Involvement of tumor cell integrin alpha v beta 3 in hematogenous metastasis of human melanoma cells.
Felding-Habermann B; Fransvea E; O'Toole TE; Manzuk L; Faha B; Hensler M
Clin Exp Metastasis; 2002; 19(5):427-36. PubMed ID: 12198771
[TBL] [Abstract][Full Text] [Related]
6. Functional activation of integrin alpha V beta 3 in tumor cells expressing membrane-type 1 matrix metalloproteinase.
Deryugina EI; Bourdon MA; Jungwirth K; Smith JW; Strongin AY
Int J Cancer; 2000 Apr; 86(1):15-23. PubMed ID: 10728589
[TBL] [Abstract][Full Text] [Related]
7. MMP-2 expression in uveal melanoma: differential activation status dictated by the cellular environment.
Bérubé M; Deschambeault A; Boucher M; Germain L; Petitclerc E; Guérin SL
Mol Vis; 2005 Dec; 11():1101-11. PubMed ID: 16379022
[TBL] [Abstract][Full Text] [Related]
8. Alpha-V-dependent outside-in signaling is required for the regulation of CD44 surface expression, MMP-2 secretion, and cell migration by osteopontin in human melanoma cells.
Samanna V; Wei H; Ego-Osuala D; Chellaiah MA
Exp Cell Res; 2006 Jul; 312(12):2214-30. PubMed ID: 16631740
[TBL] [Abstract][Full Text] [Related]
9. Molecular determinants of glioma cell migration and invasion.
Wild-Bode C; Weller M; Wick W
J Neurosurg; 2001 Jun; 94(6):978-84. PubMed ID: 11409528
[TBL] [Abstract][Full Text] [Related]
10. Bone sialoprotein, matrix metalloproteinase 2, and alpha(v)beta3 integrin in osteotropic cancer cell invasion.
Karadag A; Ogbureke KU; Fedarko NS; Fisher LW
J Natl Cancer Inst; 2004 Jun; 96(12):956-65. PubMed ID: 15199115
[TBL] [Abstract][Full Text] [Related]
11. Dissecting the role of matrix metalloproteinases (MMP) and integrin alpha(v)beta3 in angiogenesis in vitro: absence of hemopexin C domain bioactivity, but membrane-Type 1-MMP and alpha(v)beta3 are critical.
Nisato RE; Hosseini G; Sirrenberg C; Butler GS; Crabbe T; Docherty AJ; Wiesner M; Murphy G; Overall CM; Goodman SL; Pepper MS
Cancer Res; 2005 Oct; 65(20):9377-87. PubMed ID: 16230401
[TBL] [Abstract][Full Text] [Related]
12. Molecular role(s) for integrins in human melanoma invasion.
Seftor RE; Seftor EA; Hendrix MJ
Cancer Metastasis Rev; 1999; 18(3):359-75. PubMed ID: 10721490
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
Yamamoto M; Mohanam S; Sawaya R; Fuller GN; Seiki M; Sato H; Gokaslan ZL; Liotta LA; Nicolson GL; Rao JS
Cancer Res; 1996 Jan; 56(2):384-92. PubMed ID: 8542596
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of alpha(v)beta3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions.
Natali PG; Hamby CV; Felding-Habermann B; Liang B; Nicotra MR; Di Filippo F; Giannarelli D; Temponi M; Ferrone S
Cancer Res; 1997 Apr; 57(8):1554-60. PubMed ID: 9108459
[TBL] [Abstract][Full Text] [Related]
15. Integrin alphavbeta3 mediates K1735 murine melanoma cell motility in vivo and in vitro.
Li X; Regezi J; Ross FP; Blystone S; Ilić D; Leong SP; Ramos DM
J Cell Sci; 2001 Jul; 114(Pt 14):2665-72. PubMed ID: 11683393
[TBL] [Abstract][Full Text] [Related]
16. Alpha v-integrins in human melanoma: gain of alpha v beta 3 and loss of alpha v beta 5 are related to tumor progression in situ but not to metastatic capacity of cell lines in nude mice.
Danen EH; Jansen KF; Van Kraats AA; Cornelissen IM; Ruiter DJ; Van Muijen GN
Int J Cancer; 1995 May; 61(4):491-6. PubMed ID: 7538977
[TBL] [Abstract][Full Text] [Related]
17. The type I collagen induction of MT1-MMP-mediated MMP-2 activation is repressed by alphaVbeta3 integrin in human breast cancer cells.
Borrirukwanit K; Lafleur MA; Mercuri FA; Blick T; Price JT; Fridman R; Pereira JJ; Leardkamonkarn V; Thompson EW
Matrix Biol; 2007 May; 26(4):291-305. PubMed ID: 17175151
[TBL] [Abstract][Full Text] [Related]
18. Integrin beta 3 cDNA transfection into a highly metastatic alpha v beta 3-negative human melanoma cell line inhibits invasion and experimental metastasis.
Danen EH; van Kraats AA; Cornelissen IM; Ruiter DJ; van Muijen GN
Biochem Biophys Res Commun; 1996 Sep; 226(1):75-81. PubMed ID: 8806594
[TBL] [Abstract][Full Text] [Related]
19. Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD), a novel actor in invasive growth, controls matrix metalloproteinase activity.
Lunter PC; van Kilsdonk JW; van Beek H; Cornelissen IM; Bergers M; Willems PH; van Muijen GN; Swart GW
Cancer Res; 2005 Oct; 65(19):8801-8. PubMed ID: 16204050
[TBL] [Abstract][Full Text] [Related]
20. Role of alphavbeta3 integrin receptor in the invasive potential of human cervical cancer (SiHa) cells.
Chatterjee N; Chatterjee A
J Environ Pathol Toxicol Oncol; 2001; 20(3):211-21. PubMed ID: 11797830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
